Global contract manufacturing and research organisation AMRI has promoted Steven Hagen to the position of senior vice president of pharmaceutical development and manufacturing. He will continue to report to AMRI chairman, president and CEO Thomas D’Ambra.
Hagen is responsible for approximately two-thirds of AMRI’s contract operations, including chemical development, analytical and pharmaceutical quality services, small scale cGMP manufacturing of active ingredients and dosage forms, and large-scale commercial manufacturing.
Hagen joined AMRI in 2005 as senior director of analytical quality services and has risen to positions of increasing responsibility. In 2006, he was promoted to vice president for quality and analytical chemistry and was responsible for analytical chemistry, quality assurance and regulatory affairs for all AMRI locations. In 2008, he moved up to vice president of pharmaceutical development and manufacturing.
Prior to AMRI, Hagen spent more than 10 years at Pfizer in positions of increasing responsibility culminating in director of analytical research and development at Pfizer’s Global Research and Development Division.
Before Pfizer, he managed the analytical activities at Ribi ImmunoChem Research in support of R&D, production and quality control.
